| 前收市價 | 964.40 |
| 開市 | 965.00 |
| 買盤 | 981.40 x 0 |
| 賣出價 | 981.60 x 0 |
| 今日波幅 | 965.00 - 986.20 |
| 52 週波幅 | 887.00 - 1,316.75 |
| 成交量 | |
| 平均成交量 | 3,643,685 |
| 市值 | 8.577B |
| Beta 值 (5 年，每月) | 0.51 |
| 市盈率 (最近 12 個月) | 40.88 |
| 每股盈利 (最近 12 個月) | 0.24 |
| 業績公佈日 | 2024年2月27日 |
| 遠期股息及收益率 | 0.30 (3.09%) |
| 除息日 | 2024年3月28日 |
| 1 年預測目標價 | 12.88 |
Insider MonkeyHere’s Why You Should Invest in Smith & Nephew plc (SNN)
Oakmark Funds, advised by Harris Associates, released its “Oakmark International Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here. For the quarter ended March 31, 2024, the fund returned 0.11% compared to the MSCI World ex U.S. Index benchmark’s 5.59% return. Since its inception in September 1992, the fund returned an […]
InvestorPlace7 Robotic Surgery Stocks to Buy for the Future of Healthcare
There are some robotic surgery stocks for investors to buy in March this year. The growth of robotic-assisted surgery has been driven by its potential benefits, such as smaller incisions, reduced pain and scarring, quicker recovery times, and improved clinical outcomes. I think that investing in robotic surgery stocks is an underrated thematic choice for investors. The reason being is that there is currently a very low industry penetration of using robots in the surgical market, which means ther
Insider MonkeySmith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript
Smith & Nephew plc (NYSE:SNN) Q4 2023 Earnings Call Transcript February 28, 2024 Smith & Nephew plc isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Deepak Nath: Good morning and welcome to the Smith & Nephew Q4 and Full Year ‘23 […]
